Gilead Sciences Files Q3 2024 10-Q
Ticker: GILD · Form: 10-Q · Filed: 2024-11-12T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, healthcare, biotechnology
TL;DR
Gilead's Q3 2024 10-Q is in. Check financials and legal updates.
AI Summary
Gilead Sciences, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quarter. Key financial figures and business segment performance are presented, along with disclosures on legal matters and risk factors relevant to the company's ongoing operations.
Why It Matters
This filing provides investors and analysts with the latest financial health and strategic direction of Gilead Sciences, influencing investment decisions and market perception.
Risk Assessment
Risk Level: medium — The filing contains standard disclosures for a public company, including potential legal and operational risks, but no immediate crisis is indicated.
Key Numbers
- 2024-09-30 — Period End Date (Latest reported quarter)
- 2023-12-31 — Previous Year End Date (For comparison)
- 2024-01-01 — Year-to-Date Start Date (For year-to-date figures)
- 2023-01-01 — Previous Year-to-Date Start Date (For year-to-date comparison)
Key Players & Entities
- GILEAD SCIENCES, INC. (company) — Filer
- 20240930 (date) — Period of Report
- 20241112 (date) — Filing Date
- 333 LAKESIDE DR (address) — Business Address
- FOSTER CITY, CA (address) — Business Address City/State
- 94404 (zip_code) — Business Address Zip
FAQ
What were Gilead Sciences' product revenues for the third quarter of 2024?
The filing indicates product revenues for the period July 1, 2024 to September 30, 2024, but the specific dollar amount is not directly extractable from the provided snippet.
What is the filing date for this 10-Q report?
The filing date for this 10-Q report is November 12, 2024.
What is the reporting period covered by this 10-Q?
This 10-Q report covers the period ending September 30, 2024.
Where is Gilead Sciences, Inc. headquartered?
Gilead Sciences, Inc. is headquartered at 333 Lakeside Dr, Foster City, CA 94404.
What is the SIC code for Gilead Sciences, Inc.?
The Standard Industrial Classification (SIC) code for Gilead Sciences, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
From the Filing
0000882095-24-000028.txt : 20241112 0000882095-24-000028.hdr.sgml : 20241112 20241112083610 ACCESSION NUMBER: 0000882095-24-000028 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 84 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241112 DATE AS OF CHANGE: 20241112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GILEAD SCIENCES, INC. CENTRAL INDEX KEY: 0000882095 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943047598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-19731 FILM NUMBER: 241443773 BUSINESS ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6505743000 MAIL ADDRESS: STREET 1: 333 LAKESIDE DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GILEAD SCIENCES INC DATE OF NAME CHANGE: 19930328 10-Q 1 gild-20240930.htm FORM 10-Q gild-20240930 0000882095 12/31 2024 Q3 false 223 822 xbrli:shares iso4217:USD iso4217:USD xbrli:shares iso4217:EUR xbrli:pure gild:designee gild:agreement gild:patent gild:claim gild:lawsuit gild:plaintiff 0000882095 2024-01-01 2024-09-30 0000882095 2024-10-31 0000882095 2024-09-30 0000882095 2023-12-31 0000882095 us-gaap:ProductMember 2024-07-01 2024-09-30 0000882095 us-gaap:ProductMember 2023-07-01 2023-09-30 0000882095 us-gaap:ProductMember 2024-01-01 2024-09-30 0000882095 us-gaap:ProductMember 2023-01-01 2023-09-30 0000882095 gild:RoyaltyContractAndOtherMember 2024-07-01 2024-09-30 0000882095 gild:RoyaltyContractAndOtherMember 2023-07-01 2023-09-30 0000882095 gild:RoyaltyContractAndOtherMember 2024-01-01 2024-09-30 0000882095 gild:RoyaltyContractAndOtherMember 2023-01-01 2023-09-30 0000882095 2024-07-01 2024-09-30 0000882095 2023-07-01 2023-09-30 0000882095 2023-01-01 2023-09-30 0000882095 us-gaap:CommonStockMember 2024-06-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-06-30 0000882095 us-gaap:RetainedEarningsMember 2024-06-30 0000882095 us-gaap:NoncontrollingInterestMember 2024-06-30 0000882095 2024-06-30 0000882095 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-07-01 2024-09-30 0000882095 us-gaap:CommonStockMember 2024-07-01 2024-09-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2024-07-01 2024-09-30 0000882095 us-gaap:CommonStockMember 2024-09-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0000882095 us-gaap:RetainedEarningsMember 2024-09-30 0000882095 us-gaap:NoncontrollingInterestMember 2024-09-30 0000882095 us-gaap:CommonStockMember 2023-12-31 0000882095 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000882095 us-gaap:RetainedEarningsMember 2023-12-31 0000882095 us-gaap:NoncontrollingInterestMember 2023-12-31 0000882095 us-gaap:RetainedEarningsMember 2024-01-01 2024-09-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-09-30 0000882095 us-gaap:CommonStockMember 2024-01-01 2024-09-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-09-30 0000882095 us-gaap:CommonStockMember 2023-06-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0000882095 us-gaap:RetainedEarningsMember 2023-06-30 0000882095 us-gaap:NoncontrollingInterestMember 2023-06-30 0000882095 2023-06-30 0000882095 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000882095 us-gaap:NoncontrollingInterestMember 2023-07-01 2023-09-30 0000882095 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0000882095 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000882095 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000